github.com/mims-harvard/ToolUniverse
| Skill | Added | Review |
|---|---|---|
tooluniverse-cancer-classification plugin/skills/tooluniverse-cancer-classification/SKILL.md Translate free-text tumor descriptions to OncoTree codes and resolve cancer subtypes/tissue hierarchy. Cross-references UMLS/NCI vocabularies. Use for standardizing cancer-type nomenclature in EHR free-text, building cohorts in OncoKB or GDC, mapping tumor-board notes to ontology codes, and ensuring consistent terminology across cancer-genomics pipelines. | 68 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-cancer-classification plugins/tooluniverse/skills/tooluniverse-cancer-classification/SKILL.md Translate free-text tumor descriptions to OncoTree codes and resolve cancer subtypes/tissue hierarchy. Cross-references UMLS/NCI vocabularies. Use for standardizing cancer-type nomenclature in EHR free-text, building cohorts in OncoKB or GDC, mapping tumor-board notes to ontology codes, and ensuring consistent terminology across cancer-genomics pipelines. | 69 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-cancer-genomics-tcga plugin/skills/tooluniverse-cancer-genomics-tcga/SKILL.md TCGA/GDC cancer genomics analysis — cohort construction, clinical metadata retrieval, somatic mutation frequencies, survival analysis, and multi-omics integration. Use for TCGA-BRCA-style cohort studies, mutation prevalence by cancer type, survival-by-mutation analysis, and pan-cancer driver discovery. Always cancer-type-specific (don't use pan-cancer counts without cohort context). | 64 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-cancer-genomics-tcga plugins/tooluniverse/skills/tooluniverse-cancer-genomics-tcga/SKILL.md TCGA/GDC cancer genomics analysis — cohort construction, clinical metadata retrieval, somatic mutation frequencies, survival analysis, and multi-omics integration. Use for TCGA-BRCA-style cohort studies, mutation prevalence by cancer type, survival-by-mutation analysis, and pan-cancer driver discovery. Always cancer-type-specific (don't use pan-cancer counts without cohort context). | 66 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-cancer-variant-interpretation plugin/skills/tooluniverse-cancer-variant-interpretation/SKILL.md Clinical interpretation of somatic cancer mutations for precision oncology. Transforms a gene + variant + cancer-type input into an actionable report: clinical evidence tier (CIViC, OncoKB), therapeutic options (FDA-approved + investigational), resistance mechanisms, prognosis, and matching clinical trials. Use for tumor-board variant calls, somatic-mutation actionability assessment, and treatment selection. Always cancer-type-specific. | 64 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-cancer-variant-interpretation plugins/tooluniverse/skills/tooluniverse-cancer-variant-interpretation/SKILL.md Clinical interpretation of somatic cancer mutations for precision oncology. Transforms a gene + variant + cancer-type input into an actionable report: clinical evidence tier (CIViC, OncoKB), therapeutic options (FDA-approved + investigational), resistance mechanisms, prognosis, and matching clinical trials. Use for tumor-board variant calls, somatic-mutation actionability assessment, and treatment selection. Always cancer-type-specific. | 73 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-cell-line-profiling plugin/skills/tooluniverse-cell-line-profiling/SKILL.md Cancer cell-line selection and profiling for experimental model choice. Cross-references DepMap, Cellosaurus, COSMIC, PharmacoDB to deliver identity verification, mutation/CNV profile, gene dependencies, drug sensitivities, and druggable targets. Use to answer 'which cell line should I use for studying gene X?' or 'is this cell line a good model for cancer Y?'. Outputs ranked recommendations with rationale, growth characteristics, and known pitfalls. | 73 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-chemical-compound-retrieval plugin/skills/tooluniverse-chemical-compound-retrieval/SKILL.md Retrieve chemical compound data from PubChem and ChEMBL with disambiguation, cross-referencing, and stereochemistry handling. Use for resolving compound names to SMILES/InChI/CID/ChEMBL IDs (including OPSIN deterministic IUPAC-name-to-structure parsing), fetching molecular properties, distinguishing isomers/stereo forms, and cross-validating identity across databases. Always use English compound names; flags ambiguous queries (e.g., Vitamin D has multiple forms). | 71 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-chemical-compound-retrieval plugins/tooluniverse/skills/tooluniverse-chemical-compound-retrieval/SKILL.md Retrieve chemical compound data from PubChem and ChEMBL with disambiguation, cross-referencing, and stereochemistry handling. Use for resolving compound names to SMILES/InChI/CID/ChEMBL IDs (including OPSIN deterministic IUPAC-name-to-structure parsing), fetching molecular properties, distinguishing isomers/stereo forms, and cross-validating identity across databases. Always use English compound names; flags ambiguous queries (e.g., Vitamin D has multiple forms). | 72 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-chemical-safety plugin/skills/tooluniverse-chemical-safety/SKILL.md Chemical safety and toxicology assessment integrating ADMET-AI predictions, CTD toxicogenomics, PubChemTox experimental data, GHS/IARC hazard classification, and exposure-context analysis. Use for chemical hazard identification, occupational/consumer-product toxicity, dose-response evaluation, and acute (LD50) vs chronic toxicity assessment. Distinguishes drug toxicity from environmental chemical toxicity. | 64 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-chemical-sourcing plugin/skills/tooluniverse-chemical-sourcing/SKILL.md Find commercial sources for chemical compounds — PubChem/ChEMBL identity resolution then vendor catalog search across ZINC, Enamine, eMolecules, Mcule. Compares pricing, availability, and identifies purchasable analogs when an exact compound is not in stock. Use for chemical procurement, virtual library curation, and 'where can I buy X' questions for synthesis planning. | 72 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-chemical-sourcing plugins/tooluniverse/skills/tooluniverse-chemical-sourcing/SKILL.md Find commercial sources for chemical compounds — PubChem/ChEMBL identity resolution then vendor catalog search across ZINC, Enamine, eMolecules, Mcule. Compares pricing, availability, and identifies purchasable analogs when an exact compound is not in stock. Use for chemical procurement, virtual library curation, and 'where can I buy X' questions for synthesis planning. | 68 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-claude-code-plugin plugin/skills/tooluniverse-claude-code-plugin/SKILL.md Install the ToolUniverse Claude Code plugin in one step — provides MCP server with 2,700+ scientific tools, 160+ research skills, slash commands, hooks, and the research agent. Use for first-time plugin install, troubleshooting plugin not loading, verifying MCP server connection, listing API key requirements, or configuring auto-update. | 68 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-clinical-data-integration plugin/skills/tooluniverse-clinical-data-integration/SKILL.md End-to-end drug safety review integrating FDA labels, FAERS adverse event reports, PRR/ROR disproportionality, pharmacogenomic biomarkers, clinical trial data, and published literature. Use for regulatory drug safety reviews, comprehensive pharmacovigilance reports, label-vs-real-world AE comparison, and clinical decision support for drug safety. | 67 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-clinical-data-integration plugins/tooluniverse/skills/tooluniverse-clinical-data-integration/SKILL.md End-to-end drug safety review integrating FDA labels, FAERS adverse event reports, PRR/ROR disproportionality, pharmacogenomic biomarkers, clinical trial data, and published literature. Use for regulatory drug safety reviews, comprehensive pharmacovigilance reports, label-vs-real-world AE comparison, and clinical decision support for drug safety. | 68 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-clinical-guidelines plugin/skills/tooluniverse-clinical-guidelines/SKILL.md Search and retrieve clinical practice guidelines from 12+ authoritative sources — NICE, WHO, NCCN, AHA, ADA, SIGN, USPSTF, IDSA, NIH consensus, ESMO/ESC/EASL European societies, and US specialty associations. Use for evidence-graded treatment recommendations, dosing protocols, screening guidance, and authoritative-source-prioritized clinical guidance (NICE/WHO ranked above society guidelines). | 61 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-clinical-guidelines plugins/tooluniverse/skills/tooluniverse-clinical-guidelines/SKILL.md Search and retrieve clinical practice guidelines from 12+ authoritative sources — NICE, WHO, NCCN, AHA, ADA, SIGN, USPSTF, IDSA, NIH consensus, ESMO/ESC/EASL European societies, and US specialty associations. Use for evidence-graded treatment recommendations, dosing protocols, screening guidance, and authoritative-source-prioritized clinical guidance (NICE/WHO ranked above society guidelines). | 65 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a | |
tooluniverse-clinical-risk-scoring plugin/skills/tooluniverse-clinical-risk-scoring/SKILL.md Compute and interpret validated bedside clinical risk scores and pretest probabilities for an INDIVIDUAL patient — pick the right score for the scenario, gather inputs, run the deterministic calculator tool, and read the result against an interpretation table. Covers CHA2DS2-VASc (AF stroke risk), HAS-BLED (bleeding on anticoagulation), CURB-65 (pneumonia severity / admit decision), qSOFA (sepsis screen), Child-Pugh + MELD-Na (cirrhosis severity / transplant priority), Wells DVT and Wells PE (VTE pretest probability), ASCVD (10-year cardiovascular risk / statin decision), and eGFR CKD-EPI (kidney function / drug dosing). Use when asked things like "stroke risk for this AF patient", "should this patient be anticoagulated", "pneumonia severity — admit or not?", "sepsis screen this patient", "DVT/PE pretest probability", "10-year cardiovascular risk", "cirrhosis severity / MELD score", or "eGFR / kidney function". Pairs CHA2DS2-VASc with HAS-BLED to weigh anticoagulation. NOT for polygenic/genetic risk (use tooluniverse-polygenic-risk-score), NOT for population-level epidemiology/incidence (use tooluniverse-epidemiological-analysis), and NOT for diagnostic test sensitivity/specificity/likelihood-ratio math (use tooluniverse-diagnostic-test-evaluation). | — | |
tooluniverse-clinical-risk-scoring plugins/tooluniverse/skills/tooluniverse-clinical-risk-scoring/SKILL.md Compute and interpret validated bedside clinical risk scores and pretest probabilities for an INDIVIDUAL patient — pick the right score for the scenario, gather inputs, run the deterministic calculator tool, and read the result against an interpretation table. Covers CHA2DS2-VASc (AF stroke risk), HAS-BLED (bleeding on anticoagulation), CURB-65 (pneumonia severity / admit decision), qSOFA (sepsis screen), Child-Pugh + MELD-Na (cirrhosis severity / transplant priority), Wells DVT and Wells PE (VTE pretest probability), ASCVD (10-year cardiovascular risk / statin decision), and eGFR CKD-EPI (kidney function / drug dosing). Use when asked things like "stroke risk for this AF patient", "should this patient be anticoagulated", "pneumonia severity — admit or not?", "sepsis screen this patient", "DVT/PE pretest probability", "10-year cardiovascular risk", "cirrhosis severity / MELD score", or "eGFR / kidney function". Pairs CHA2DS2-VASc with HAS-BLED to weigh anticoagulation. NOT for... | 77 Impact — No eval scenarios have been run Securityby Passed No findings from the security scan Version: 37bb81a | |
tooluniverse-clinical-trial-design plugin/skills/tooluniverse-clinical-trial-design/SKILL.md Strategic clinical trial design feasibility assessment. Analyzes 6 dimensions (endpoint, population, comparator, effect size, duration, regulatory pathway) using precedent trials and FDA guidance. Produces enrollment projections, endpoint recommendations, and approval-pathway analysis. Use for trial-protocol design, power/sample-size estimation, comparator selection, and FDA submission strategy. Driven by precedent-based reasoning rather than first-principles math. | 60 Impact — No eval scenarios have been run Securityby Low Low-risk findings worth noting Version: 37bb81a |